Global Vulvovaginal Candidiasis Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Vulvovaginal Candidiasis Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2048033
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.
The Vulvovaginal Candidiasis market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Vulvovaginal Candidiasis market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Vulvovaginal Candidiasis Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Vulvovaginal Candidiasis market are:
Kingyork Group
Sanofi
Pfizer
Bayer
J & J
Teva
Effik
Cisen Pharmaceutical
Perrigo
Bristol-Myers Squibb

Most important types of Vulvovaginal Candidiasis products covered in this report are:
Miconazole
Clotrimazole
Fluconazole
Econazole
Other

Most widely used downstream fields of Vulvovaginal Candidiasis market covered in this report are:
Hospital & Clinic
Pharmacy

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Table of Content 

Table of Content

1 Vulvovaginal Candidiasis Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Vulvovaginal Candidiasis
1.3 Vulvovaginal Candidiasis Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Vulvovaginal Candidiasis Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Vulvovaginal Candidiasis
1.4.2 Applications of Vulvovaginal Candidiasis
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Vulvovaginal Candidiasis Industry Trends
1.5.2 Vulvovaginal Candidiasis Drivers
1.5.3 Vulvovaginal Candidiasis Market Challenges
1.5.4 Vulvovaginal Candidiasis Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Vulvovaginal Candidiasis Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Vulvovaginal Candidiasis Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Vulvovaginal Candidiasis Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Vulvovaginal Candidiasis
2.2.1 Major Players Manufacturing Base of Vulvovaginal Candidiasis in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Vulvovaginal Candidiasis Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Vulvovaginal Candidiasis
2.3.3 Labor Cost of Vulvovaginal Candidiasis
2.4 Market Channel Analysis of Vulvovaginal Candidiasis
2.5 Major Down Stream Customers by Application

3 Global Vulvovaginal Candidiasis Market, by Type
3.1 Global Vulvovaginal Candidiasis Revenue and Market Share by Type (2018-2021)
3.2 Global Vulvovaginal Candidiasis Production and Market Share by Type (2018-2021)
3.3 Global Vulvovaginal Candidiasis Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Vulvovaginal Candidiasis Revenue and Growth Rate of Miconazole
3.3.2 Global Vulvovaginal Candidiasis Revenue and Growth Rate of Clotrimazole
3.3.3 Global Vulvovaginal Candidiasis Revenue and Growth Rate of Fluconazole
3.3.4 Global Vulvovaginal Candidiasis Revenue and Growth Rate of Econazole
3.3.5 Global Vulvovaginal Candidiasis Revenue and Growth Rate of Other
3.4 Global Vulvovaginal Candidiasis Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Vulvovaginal Candidiasis Market, by Application
4.1 Downstream Market Overview
4.2 Global Vulvovaginal Candidiasis Consumption and Market Share by Application (2018-2021)
4.3 Global Vulvovaginal Candidiasis Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Vulvovaginal Candidiasis Consumption and Growth Rate of Hospital & Clinic (2018-2021)
4.3.2 Global Vulvovaginal Candidiasis Consumption and Growth Rate of Pharmacy (2018-2021)

5 Global Vulvovaginal Candidiasis Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Vulvovaginal Candidiasis Revenue and Market Share by Region (2018-2021)
5.2 Global Vulvovaginal Candidiasis Consumption and Market Share by Region (2018-2021)
5.3 Global Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Vulvovaginal Candidiasis Market Under COVID-19
5.4.2 North America Vulvovaginal Candidiasis SWOT Analysis
5.5 Europe Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Vulvovaginal Candidiasis Market Under COVID-19
5.5.2 Europe Vulvovaginal Candidiasis SWOT Analysis
5.6 China Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Vulvovaginal Candidiasis Market Under COVID-19
5.6.2 China Vulvovaginal Candidiasis SWOT Analysis
5.7 Japan Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Vulvovaginal Candidiasis Market Under COVID-19
5.7.2 Japan Vulvovaginal Candidiasis SWOT Analysis
5.8 Middle East and Africa Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Vulvovaginal Candidiasis Market Under COVID-19
5.8.2 Middle East and Africa Vulvovaginal Candidiasis SWOT Analysis
5.9 India Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Vulvovaginal Candidiasis Market Under COVID-19
5.9.2 India Vulvovaginal Candidiasis SWOT Analysis
5.10 South America Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Vulvovaginal Candidiasis Market Under COVID-19
5.10.2 South America Vulvovaginal Candidiasis SWOT Analysis
5.11 South Korea Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Vulvovaginal Candidiasis Market Under COVID-19
5.11.2 South Korea Vulvovaginal Candidiasis SWOT Analysis
5.12 Southeast Asia Vulvovaginal Candidiasis Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Vulvovaginal Candidiasis Market Under COVID-19
5.12.2 Southeast Asia Vulvovaginal Candidiasis SWOT Analysis

6 Global Vulvovaginal Candidiasis Production by Top Regions (2018-2021)
6.1 Global Vulvovaginal Candidiasis Production by Top Regions (2018-2021)
6.2 North America Vulvovaginal Candidiasis Production and Growth Rate
6.3 Europe Vulvovaginal Candidiasis Production and Growth Rate
6.4 China Vulvovaginal Candidiasis Production and Growth Rate
6.5 Japan Vulvovaginal Candidiasis Production and Growth Rate
6.6 India Vulvovaginal Candidiasis Production and Growth Rate

7 Global Vulvovaginal Candidiasis Consumption by Regions (2018-2021)
7.1 Global Vulvovaginal Candidiasis Consumption by Regions (2018-2021)
7.2 North America Vulvovaginal Candidiasis Consumption and Growth Rate
7.3 Europe Vulvovaginal Candidiasis Consumption and Growth Rate
7.4 China Vulvovaginal Candidiasis Consumption and Growth Rate
7.5 Japan Vulvovaginal Candidiasis Consumption and Growth Rate
7.6 Middle East & Africa Vulvovaginal Candidiasis Consumption and Growth Rate
7.7 India Vulvovaginal Candidiasis Consumption and Growth Rate
7.8 South America Vulvovaginal Candidiasis Consumption and Growth Rate
7.9 South Korea Vulvovaginal Candidiasis Consumption and Growth Rate
7.10 Southeast Asia Vulvovaginal Candidiasis Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Kingyork Group Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.2.3 Kingyork Group Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Sanofi Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.3.3 Sanofi Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Pfizer Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.4.3 Pfizer Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Bayer Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.5.3 Bayer Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 J & J Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.6.3 J & J Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Teva Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.7.3 Teva Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Effik Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.8.3 Effik Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Cisen Pharmaceutical Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.9.3 Cisen Pharmaceutical Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Perrigo Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.10.3 Perrigo Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Bristol-Myers Squibb Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Vulvovaginal Candidiasis Product Profiles, Application and Specification
8.11.3 Bristol-Myers Squibb Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Vulvovaginal Candidiasis Market Analysis and Forecast by Type and Application
9.1 Global Vulvovaginal Candidiasis Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Miconazole Market Revenue and Volume Forecast (2021-2026)
9.1.2 Clotrimazole Market Revenue and Volume Forecast (2021-2026)
9.1.3 Fluconazole Market Revenue and Volume Forecast (2021-2026)
9.1.4 Econazole Market Revenue and Volume Forecast (2021-2026)
9.1.5 Other Market Revenue and Volume Forecast (2021-2026)
9.2 Global Vulvovaginal Candidiasis Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital & Clinic Market Revenue and Volume Forecast (2021-2026)
9.2.2 Pharmacy Market Revenue and Volume Forecast (2021-2026)

10 Vulvovaginal Candidiasis Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Vulvovaginal Candidiasis Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Healthcare IT Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Agriculture

Defense and Aeronautics

Technology and Media

Top Rated Products